Plain-English translation of NCT06116019 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This trial is testing a new radiation therapy machine called ETHOS that can adjust your treatment plan every single day during your cancer radiation therapy. Instead of using the same plan for weeks, the machine takes a quick picture before each treatment and modifies the radiation beams in real time to match exactly where your tumor is that day. This personalized approach may help deliver better results while reducing damage to healthy tissue.
Tumors and organs move slightly during the weeks of radiation therapy, and doctors have had difficulty adjusting treatment plans quickly enough to account for these changes. This trial exists to see whether the new treatment technology can safely and practically make these daily adjustments, and whether adding patient feedback about side effects can improve the overall care.
You likely qualify if…
You likely don't qualify if…
You will receive radiation therapy using the ETHOS machine over several weeks of treatment. Before each session, the machine takes a quick imaging scan to see the current position of your tumor, and the treatment plan is adjusted based on what it sees. Throughout your treatment, you will also be asked to share feedback about any side effects you experience, which helps doctors track how the treatment is affecting you.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Germany
Sponsor
Charite University, Berlin, Germany
Enrollment target
~649 participants
Started
October 2023
Primary completion
October 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Goda Kalinauskaite, MD
Charite University, Berlin, Germany
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.